Published October 7, 2026 | Version v1

MODERN TRENDS IN NATURAL ANTIBIOTIC DISCOVERY

  • 1. Shemyakin-Ovchinnikov Institute of Bioorganic Chemistry, Russia
  • 1. Yunusov Institute of the Chemistry of Plant Substances

Description

Natural compounds remain a major source of novel drug candidates with intriguing biological activities. Recently, we isolated a new family of peptide antibiotics, named gausemycins, which display striking structural novelty and an original membrane-associated mechanism of antibacterial activity [1,2]. Modern natural product discovery is increasingly focused on rare microbial taxa, silent biosynthetic gene clusters, and condition-specific secondary metabolites [3]. However, conventional antibiotic discovery workflows remain labor-intensive, require relatively large culture volumes, and often explore only a limited number of cultivation conditions. This restricts access to the "microbial dark antibiome": antimicrobial metabolites produced only by rare strains or under specific cultivation regimes. In this context, miniaturization represents one of the most promising strategies for expanding antibiotic discovery pipelines [4].

Files

paper-6abc5f6d72cc9ebae3306106.pdf

Files (678.9 kB)

Name Size
md5:04e92849ad12d0c654bf78b47c186e0e
678.9 kB Preview Download

Additional details

References

  • Tyurin, A.P.; Alferova, V.A.; Paramonov, A.S. et al. Angew. Chem. Int. Ed. 2021, 60, 18694–18703, doi:10.1002/anie.202104528.
  • Kravchenko, T.V.; Paramonov, A.S.; Kudzhaev, A.M. et al. J. Nat. Prod. 2024, 87, 664–674, doi:10.1021/acs.jnatprod.3c00612.
  • Baranova, A.A.; Alferova, V.A.; Korshun, V.A.; Tyurin, A.P. Life 2023, 13, 1073, doi:10.3390/life13051073.
  • Zhitlov, M.Y.; Korshun, V.A.; Alferova, V.A. Antibiotics 2025, 14, 1232, doi:10.3390/antibiotics14121232.